[1] LEVY C F, OO K Z, FIREMAN F, et al. Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab[J]. Pediatr Blood Cancer, 2009, 52(5): 669-671.
[2] PALMA J A, GOMEZ-IBA?EZ A, MARTIN B, et al. Nonconvulsive status epilepticus related to posterior reversible leukoencephalopathy syndrome induced by cetuximab[J]. Neurologist, 2011, 17(5): 273-275.
[3] CHELIS L, SOUFTAS V, AMARANTIDIS K, et al. Reversible posterior leukoencephalopathy syndrome induced by pazopanib[J].
BMC Cancer, 2012, 12: 489.
[4] PADHY B M, SHANMUGAM S P, GUPTA Y K, et al. Reversible posterior leucoencephalopathy syndrome in an elderly male on
sunitinib therapy[J]. Br J Clin Pharmacol, 2011, 71(5): 777-779.
[5] FEMIA G, HARDY T A, SPIES J M, et al. Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin
and a fluoropyrimidine: a case report and literature review[J]. Asia Pac J Clin Oncol, 2012, 8(2): 115-122.
[6] MAHARAJ A S, WALSHE T E, SAINT-GENIEZ M, et al. VEGF and TGF-β are required for the maintenance of the choroid
plexus and ependyma[J]. J Exp Med, 2008, 205(2): 491-501.
[7] SCLAFANI F, GIUSEPPE G, MEZYNKSI J, et al. Reversible posterior leukoencephalopathy syndrome and bevacizumab in breast
cancer[J]. J Clin Oncol, 2012, 30(26): e257-e259.
[8] YILMAZ S, GOKBEN S, ARIKAN C, et al. Reversibility of cytotoxic oedema in tacrolimus leukoencephalopathy[J]. Pediatr Neurol,2010, 43(5): 359- 362.
[9] SEET R C, RABINSTEIN A A. Clinical features and outcomes of posterior reversible encephalopathy syndrome following
bevacizumab treatment[J]. QJM, 2012, 105(1): 69-75.
[10] CHANG Y, MBEO G, LITTMAN S J. Reversible posterior leukoencephalopathy syndrome associated with concurrent
bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma[J]. J Gastrointest Cancer, 2012, 43(3): 505-507.
[11] NAGATA Y, OMURO Y, SHIMOYAMA T, et al. A case of colon cancer with reversible posterior leukoencephalopathy syndrome
following 5-FU and oxaliplatin (FOLFOX regime) [J]. Gan To Kagaku Ryoho, 2009, 36(7): 1163-1166. |
